Klement, R. J., Boda-Heggemann, J., & Habermehl, D. (2017). Stereotactic body radiotherapy for oligo-metastatic liver disease: Influence of pre-treatment chemotherapy and histology on local tumor control. Radiotherapy and oncology, 123(2), . https://doi.org/10.1016/j.radonc.2017.01.013
Chicago Style (17th ed.) CitationKlement, Rainer J., Judit Boda-Heggemann, and Daniel Habermehl. "Stereotactic Body Radiotherapy for Oligo-metastatic Liver Disease: Influence of Pre-treatment Chemotherapy and Histology on Local Tumor Control." Radiotherapy and Oncology 123, no. 2 (2017). https://doi.org/10.1016/j.radonc.2017.01.013.
MLA (9th ed.) CitationKlement, Rainer J., et al. "Stereotactic Body Radiotherapy for Oligo-metastatic Liver Disease: Influence of Pre-treatment Chemotherapy and Histology on Local Tumor Control." Radiotherapy and Oncology, vol. 123, no. 2, 2017, https://doi.org/10.1016/j.radonc.2017.01.013.